InvestorsHub Logo
Followers 2
Posts 333
Boards Moderated 0
Alias Born 07/19/2016

Re: cab033 post# 53056

Wednesday, 02/07/2018 2:08:07 PM

Wednesday, February 07, 2018 2:08:07 PM

Post# of 108192
I'm not saying I agree or disagree, I just think the market will react in a positive way well before approval. When I was in DNDN most of the increase came well before the approval date, the anticipation of approval was built into the share price months before approval. Some folks actually got out in the days preceding approval for fear it wouldn't get approved, in which case it would have been catastrophic.

As for your prediction of a $4-5 range for approval, lets do some math.
First, see my pinned post on what Advaxis might be worth if sold. In it I projected approximately 1B in sales for cervical ca alone, but that was in both the US and the EU. Let's do a rough estimate and say the EU is about twice the population of the US, so the EU gets about 2/3 of this number, say 600m in sales/yr being conservative. At 50K outstanding shares, (I know, this is too big also, again I'm being conservative) this is $12 a share. For one construct. For one indication. Considering the sp is based on multiples of yearly revenue, it's probably much higher than this. (I'm open to estimates from anyone, this board could use some positivity). Now also factor in everyone taking notice and seeing our platform and what is in the wings. Do you begin to see the potential?

I know I'll be accused of being overly optimistic, but numbers don't lie. Sure, some of my presumptions may be off, but even if it's half, we're still well above $10. So again, if you're a short looking at the possibility of $10 in under a year, are you going to cover sooner or later?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News